EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence and Molecular Characterization of β-Lactamase and Quinolone Resistance Genes in Imipenem-Non-Susceptible Uropathogenic Escherichia coli (UPEC) Isolates

Anfal Kara, Chiara Massaro, Naouel Boussoualim, Meriem Elkolli, Rosa Alduina

Frontiers in Bioscience-Landmark · 2026

DOI: 10.31083/fbl48045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Anfal Kara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Applied Biochemistry, Faculty of Nature and Life Sciences, University Ferhat Abbas of Setif 1, 19000 Setif, Algeria. Hauptthemen laut MEDLINE: beta-Lactamases, Uropathogenic Escherichia coli, Quinolones, Imipenem. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission NextGenerationEU Project SUS-MIRRI.IT, "Strengthening the MIRRI Italian Research Infrastructure for Sustainable Bioscience and Bioeconomy", European Commission NextGenerationEU, PNRR CN5 "National Biodiversity Future Center", European Commission NextGenerationEU Project SUS-MIRRI.IT, “Strengthening the MIRRI Italian Research Infrastructure for Sustainable Bioscience and Bioeconomy”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Escherichia coli is the leading cause of urinary tract infections (UTIs), and the increasing prevalence of antimicrobial resistance represents a major public health concern. The dissemination of multidrug-resistant uropathogenic E. coli (UPEC), frequently harboring transferable resistance determinants, poses an urgent clinical challenge.

Methods

This study investigated the prevalence of β-lactamase genes (blaTEM, blaSHV, blaCTX-M, blaCMY, and blaDHA) and plasmid-mediated quinolone resistance genes (qnrA, qnrB, qnrC, qnrD, and qnrS) in 86 imipenem-non-susceptible UPEC isolates using multiplex and single PCR assays. Gene distribution and co-occurrence were examined across E. coli phylogenetic groups, and pairwise associations were evaluated using correlation analysis. Principal component analysis (PCA) was applied to explore global relationships between antibiotic susceptibility profiles, extended-spectrum β-lactamase (ESBL) phenotype, and resistance determinants.

Results

Overall, 74.4% of imipenem-non-susceptible isolates carried at least one β-lactamase gene. blaTEM was the most prevalent (62.8%), followed by blaCMY II (12.8%). blaSHV, blaCTX-M group I, and blaCTX-M group II showed comparable prevalence (10.5% each). The B2 phylogroup showed the greatest diversity of β-lactamase profiles, with phylogroup E representing the second most frequent reservoir. Among quinolone resistance genes, qnrB was the most prevalent (20.9%), followed by qnrD (5.8%), qnrS (4.7%), qnrA (3.5%), and qnrC (1.2%). All qnrC-positive isolates were resistant to all tested quinolones. No statistically significant associations were observed between β-lactamase genes and qnr genes. Significant within-class correlations were detected for blaCTX-M group II–blaCMY II (φ = 0.893, q = 9.33 × 10–9) and qnrC–qnrA (φ = 0.57, q = 0.374).

Conclusions

A high prevalence of β-lactamase and qnr determinants was observed among imipenem-non-susceptible UPEC, primarily driven by blaTEM and qnrB, frequently detected in B2 isolates. The co-occurrence and correlation of multiple resistance genes highlight the complexity of resistance architectures and underscore the need for ongoing molecular surveillance and strengthened antimicrobial stewardship to limit the dissemination of resistant UPEC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesUropathogenic Escherichia coliQuinolonesImipenemEscherichia coli InfectionsDrug Resistance, Multiple, BacterialHumansAnti-Bacterial AgentsUrinary Tract InfectionsPrevalenceMicrobial Sensitivity TestsPhylogeny

Stichwörter der Autor:innen

antimicrobial resistanceextended-spectrum β-lactamases (ESBL)phylogroupsplasmid-mediated quinolone resistance (PMQR)public healthurinary tract infection (UTI)uropathogenic Escherichia coli (UPEC)β-lactamase genes

Substanzen

beta-LactamasesQuinolonesImipenemAnti-Bacterial Agents

Autor:innen und Institutionen

  • Laboratory of Applied Biochemistry, Faculty of Nature and Life Sciences, University Ferhat Abbas of Setif 1, 19000 Setif, Algeria.
  • Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, 90128 Palermo, Italy.
  • Laboratory of Microbiology, Faculty of Nature and Life Sciences, University Ferhat Abbas of Setif 1, 19000 Setif, Algeria.
  • NBFC, National Biodiversity Future Center, 90133 Palermo, Italy.

Förderung

  • European Commission NextGenerationEU Project SUS-MIRRI.IT, "Strengthening the MIRRI Italian Research Infrastructure for Sustainable Bioscience and Bioeconomy"
  • European Commission NextGenerationEU, PNRR CN5 "National Biodiversity Future Center"
  • European Commission NextGenerationEU Project SUS-MIRRI.IT, “Strengthening the MIRRI Italian Research Infrastructure for Sustainable Bioscience and Bioeconomy”
  • European Commission NextGenerationEU, PNRR CN5 “National Biodiversity Future Center”

Zitieren

APA

Kara, A., Massaro, C., Boussoualim, N., Elkolli, M., & Alduina, R. (2026). Prevalence and Molecular Characterization of β-Lactamase and Quinolone Resistance Genes in Imipenem-Non-Susceptible Uropathogenic Escherichia coli (UPEC) Isolates. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl48045

Vancouver

Kara A, Massaro C, Boussoualim N, Elkolli M, Alduina R. Prevalence and Molecular Characterization of β-Lactamase and Quinolone Resistance Genes in Imipenem-Non-Susceptible Uropathogenic Escherichia coli (UPEC) Isolates. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl48045

BibTeX
@article{Kara2026,
  author = {Kara, Anfal and Massaro, Chiara and Boussoualim, Naouel and Elkolli, Meriem and Alduina, Rosa},
  title = {Prevalence and Molecular Characterization of β-Lactamase and Quinolone Resistance Genes in Imipenem-Non-Susceptible Uropathogenic Escherichia coli (UPEC) Isolates},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  doi = {10.31083/fbl48045}
}
Kostenlos starten →